Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01490892 · ClinicalTrials.gov registry record · Phase 4
Quantitative Subharmonic Breast Imaging
A Phase 4 study of Breast Cancer, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 4
- Development phase
- 219
- Enrollment target
- 2
- Study locations
NCT01490892 is a Phase 4 study of Breast Cancer that has completed, run by Thomas Jefferson University. The registered enrollment target is 219 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01490892, a Phase 4 study of Breast Cancer, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 219 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a non-randomized trial of 450 women with a breast abnormality, who are scheduled for a breast biopsy of this abnormality. The study will be conducted at two clinical sites. The primary objective of this trial is: To evaluate if quantitative 3D Subharmonic imaging (SHI) or pulse inversion harmonic imaging (HI) can improve the characterization of benign and malignant breast masses (independently or in combination with other imaging modes) compared to x-ray mammography, fundamental grayscale ultrasound (US) or power Doppler imaging (PDI). The secondary aim of this trial is: To compare quantitative (bifurcations \& vessel length) and semi-quantitative (blood pool \& parametric imaging) measures of the vascular morphology of breast lesions determined by pathology and by SHI.
Conditions Studied
Interventions
- DRUG 3D HI and SHI of UCA
Study Locations (2)
California
- University of California, San Diego - La Jolla
Pennsylvania
- Thomas Jefferson University, Dept of Radiology - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2011-11 |
| Est. Completion | 2019-04-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01490892
The ClinicalTrials.gov registry entry for NCT01490892 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which 3D HI and SHI of UCA is the first listed.
NCT01490892 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01490892 about?
NCT01490892 is a clinical study titled "Quantitative Subharmonic Breast Imaging". This is a non-randomized trial of 450 women with a breast abnormality, who are scheduled for a breast biopsy of this abnormality. The study will be conducted at two clinical sites. The primary objective of this trial is: To evaluate if quantitative 3D Subharmonic imaging (SHI) or pulse inversion ha...
What is the current status of trial NCT01490892?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 219 participants. The study started on 2011-11. Estimated completion is 2019-04-05.
What conditions does trial NCT01490892 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01490892?
The interventions under investigation include: 3D HI and SHI of UCA (DRUG).
Who is sponsoring clinical trial NCT01490892?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01490892 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
RECRUITING · Phase 4
-
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
RECRUITING · Phase 4
-
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
RECRUITING · Phase 4
-
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
RECRUITING · Phase 4
-
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
RECRUITING · Phase 4
-
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.